Cargando…

Dasiglucagon demonstrates reduced costs in the treatment of severe hypoglycemia in a budget impact model

BACKGROUND: Approximately 7.3 million people with type 1 or type 2 diabetes (T1D/T2D) are treated with insulin, placing them at higher risk of severe hypoglycemia (SH). SH requires assistance of another individual and often necessitates the prompt administration of intravenous glucose, injectable gl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hinahara, Jordan, Weinzimer, Stuart A, Bromley, Emilie R, Goss, Thomas F, Kendall, David M, Hammer, Mette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373001/ https://www.ncbi.nlm.nih.gov/pubmed/35332789 http://dx.doi.org/10.18553/jmcp.2022.28.4.461

Ejemplares similares

A Comparative Study of Dasiglucagon Ready-to-Use Autoinjector and Glucagon Emergency Kit During Rescue from Simulated Severe Hypoglycemia
por: Bailey, Naila Celeste, et al.
Publicado: (2022)

Evaluating Ease of Use and Patient Safety of Dasiglucagon Hypo Pal Autoinjector for the Management of Hypoglycemia
por: Schaumleffel, Carol
Publicado: (2023)

Dasiglucagon for the Treatment of Insulin-induced Hypoglycemia in Patients with Type 1 Diabetes Mellitus: A Meta-analysis
por: Maji, Shampa, et al.
Publicado: (2023)

Cost of Severe Hypoglycemia and Budget Impact with Nasal Glucagon in Patients with Diabetes in Spain
por: Osumili, Beatrice, et al.
Publicado: (2022)

Dasiglucagon—A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia: Results of Phase 3 Randomized Double-Blind Clinical Trial
por: Pieber, Thomas R., et al.
Publicado: (2021)

Dasiglucagon, a next‐generation ready‐to‐use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: Results of a phase 3, randomized controlled trial
por: Battelino, Tadej, et al.
Publicado: (2021)

Efficacy and Safety of a Nonanimal Stabilized Hyaluronic Acid/Dextranomer in Improving Fecal Incontinence: A Prospective, Single-Arm, Multicenter, Clinical Study With 36-Month Follow-up
por: Quiroz, Lieschen H., et al.
Publicado: (2023)

Severe Hypoglycemia and the Use of Glucagon Rescue Agents: An Observational Survey in Adults With Type 1 Diabetes
por: Hughes, Allyson S., et al.
Publicado: (2023)

Dasiglucagon Effects on QTc in Healthy Volunteers: A Randomized, Placebo-Controlled, Dose-Escalation, Double-Blind Study
por: Tehranchi, Ramin, et al.
Publicado: (2022)

“It’s embarrassing. I get angry. I get frustrated.”: Understanding severe hypoglycemia and glucagon usage from the perspectives of people with type 1 diabetes
por: Hughes, Allyson S., et al.
Publicado: (2022)

Health-Related Quality of Life as Measured by the 36-Item Short Form Survey Among Adults With Acute Bacterial Skin and Skin Structure Infections who Received Either Omadacycline or Linezolid in a Phase 3 Double-Blind, Double-Dummy Clinical Trial
por: Chitra, Surya, et al.
Publicado: (2021)

1356. Improvement in Quality of Life for Adults With Acute Bacterial Skin and Skin Structure Infections Following Treatment With Omadacycline or Linezolid
por: Tzanis, Evan, et al.
Publicado: (2018)

Low doses of dasiglucagon consistently increase plasma glucose levels from hypoglycaemia and euglycaemia in people with type 1 diabetes mellitus
por: Hövelmann, Ulrike, et al.
Publicado: (2018)

Severe hypoglycemia reduces the shivering threshold in rabbits
por: Wada, Keiichi, et al.
Publicado: (2019)

Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting
por: Castellanos, Luz E., et al.
Publicado: (2021)

Working with Costs and Budgets
por: Institute of Leadership, et al.
Publicado: (2013)

Budget Impact of Medicaid Section 1115 Demonstrations for Early HIV Treatment
por: Schackman, Bruce R., et al.
Publicado: (2005)

Cost-Effectiveness and Budget Impact of Lumacaftor/Ivacaftor in the Treatment of Cystic Fibrosis
por: Vadagam, Pratyusha, et al.
Publicado: (2018)

Congenital hyperinsulinism in infancy and childhood: challenges, unmet needs and the perspective of patients and families
por: Banerjee, Indraneel, et al.
Publicado: (2022)

Correction to: Congenital hyperinsulinism in infancy and childhood: challenges, unmet needs and the perspective of patients and families
por: Banerjee, Indraneel, et al.
Publicado: (2022)

Reduced Hypoglycemia and Increased Time in Target Using Closed-Loop Insulin Delivery During Nights With or Without Antecedent Afternoon Exercise in Type 1 Diabetes
por: Sherr, Jennifer L., et al.
Publicado: (2013)

Severe Hypoglycemia–Induced Fatal Cardiac Arrhythmias Are Augmented by Diabetes and Attenuated by Recurrent Hypoglycemia
por: Reno, Candace M., et al.
Publicado: (2017)

Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and brochodilators for severe and very severe COPD patients
por: Negro, Roberto Dal, et al.
Publicado: (2007)

Real-Time Continuous Glucose Monitoring Significantly Reduces Severe Hypoglycemia in Hypoglycemia-Unaware Patients With Type 1 Diabetes
por: Choudhary, Pratik, et al.
Publicado: (2013)

Risk Factors of Hypoglycemic Encephalopathy and Prolonged Hypoglycemia in Patients With Severe Hypoglycemia
por: Saikawa, Rika, et al.
Publicado: (2019)

Cost-effectiveness and budget impact analyses of dengue vaccination in Indonesia
por: Suwantika, Auliya Abdurrohim, et al.
Publicado: (2021)

Cost-Effectiveness and Budget Impact Analyses of Pneumococcal Vaccination in Indonesia
por: Suwantika, Auliya A., et al.
Publicado: (2021)

Cost effectiveness and budget impact of universal varicella vaccination in Russia
por: Marijam, Alen, et al.
Publicado: (2022)

Severe Hypoglycemia in Patients with Diabetes
por: Yun, Jae Seung, et al.
Publicado: (2012)

RAVAN: CubeSat Demonstration for Multi-Point Earth Radiation Budget Measurements
por: Swartz, William H., et al.
Publicado: (2019)

Impact of endoscopic ultrasound-guided gallbladder drainage on reducing costs of reintervention and unplanned readmission: a budget impact analysis
por: Chan, Shannon Melissa, et al.
Publicado: (2022)

Hypoglycemia during moderate intensity exercise reduces counterregulatory responses to subsequent hypoglycemia
por: Cade, W. Todd, et al.
Publicado: (2016)

Unforeseen Costs of Cutting Mosquito Surveillance Budgets
por: Vazquez-Prokopec, Gonzalo M., et al.
Publicado: (2010)

Cost Variation Index - Basic Programme Budget
Publicado: (1965)

Program budgeting and benefit-cost analysis : cases, text, and readings /
Publicado: (1969)

Cost-effectiveness and budget impact of a lifestyle intervention to improve cardiometabolic health in patients with severe mental illness
por: Looijmans, Anne, et al.
Publicado: (2020)

Risk Factors for Recurrent Hypoglycemia in Hospitalized Diabetic Patients Admitted for Severe Hypoglycemia
por: Lin, Yen-Yue, et al.
Publicado: (2010)

Projected impact, cost-effectiveness, and budget implications of rotavirus vaccination in Mongolia
por: Lusvan, Munkh-Erdene, et al.
Publicado: (2019)

Handling Uncertainty in Cost-Effectiveness Analysis: Budget Impact and Risk Aversion
por: Sendi, Pedram, et al.
Publicado: (2021)

The ethics of aggregation in cost-effectiveness analysis or, “on books, bookshelves, and budget impact”
por: Charlton, Victoria
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_agcsvt7ut022b8cq8hlp7f7gu5